Foldyne Research International focuses on creating and advancing precision compounds for the treatment of diseases with unmet medical needs, in various drug classes. Our innovative approach to drug development has resulted in patentable intellectual property for compounds that are ready to advance into preclinical trials. Contact us for our translational compound catalogue and pricing.



Why purchasing or licensing-in our intellectual property on new molecular entities?

New targets for almost every orphan disease become available on a daily basis. Community wide, many pharmaceutical research teams are hunting for the winning compound in time, but only the availability of the best computational drug design tools can provide a decisive competitive advantage.

If our products might add value to your early stage drug development pipeline, we invite you to request an updated quotation. Please provide your contact details.